Weekly Recap: New and acquired product sales surge and COVID revenue decline
Pfizer Inc. (NYSE:PFE) said new product sales surged while COVID revenue will decline through 2026, unveiled clinical progress on tivunatamig and obesity candidate PF-3944, pursued big China deals and pricing/AI shifts, amid FOIA and congressional scrutiny over contracts and trials.Previous Week Re…